nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—ADRB1—stomach cancer	0.305	0.366	CbGaD
Pindolol—HTR1A—stomach cancer	0.273	0.327	CbGaD
Pindolol—ADRB2—stomach cancer	0.256	0.308	CbGaD
Pindolol—Isoprenaline—MAPK1—stomach cancer	0.000536	0.0576	CrCbGaD
Pindolol—Practolol—ADRB1—stomach cancer	0.000461	0.0496	CrCbGaD
Pindolol—Levobunolol—ADRB1—stomach cancer	0.000437	0.047	CrCbGaD
Pindolol—Metipranolol—ADRB1—stomach cancer	0.000417	0.0448	CrCbGaD
Pindolol—Carteolol—ADRB1—stomach cancer	0.000371	0.0399	CrCbGaD
Pindolol—Levobunolol—ADRB2—stomach cancer	0.000367	0.0395	CrCbGaD
Pindolol—Metipranolol—ADRB2—stomach cancer	0.000351	0.0377	CrCbGaD
Pindolol—Nadolol—ADRB1—stomach cancer	0.000331	0.0356	CrCbGaD
Pindolol—Esmolol—ADRB1—stomach cancer	0.000331	0.0356	CrCbGaD
Pindolol—Bupranolol—ADRB1—stomach cancer	0.000316	0.034	CrCbGaD
Pindolol—Carteolol—ADRB2—stomach cancer	0.000312	0.0336	CrCbGaD
Pindolol—Betaxolol—ADRB1—stomach cancer	0.000292	0.0313	CrCbGaD
Pindolol—Atenolol—ADRB1—stomach cancer	0.000289	0.0311	CrCbGaD
Pindolol—Bisoprolol—ADRB1—stomach cancer	0.000282	0.0303	CrCbGaD
Pindolol—Esmolol—ADRB2—stomach cancer	0.000278	0.0299	CrCbGaD
Pindolol—Nadolol—ADRB2—stomach cancer	0.000278	0.0299	CrCbGaD
Pindolol—Acebutolol—ADRB1—stomach cancer	0.000267	0.0287	CrCbGaD
Pindolol—Bupranolol—ADRB2—stomach cancer	0.000266	0.0286	CrCbGaD
Pindolol—Oxprenolol—ADRB1—stomach cancer	0.000265	0.0285	CrCbGaD
Pindolol—Dyspepsia—Fluorouracil—stomach cancer	0.000246	0.00235	CcSEcCtD
Pindolol—Abdominal discomfort—Methotrexate—stomach cancer	0.000245	0.00234	CcSEcCtD
Pindolol—Betaxolol—ADRB2—stomach cancer	0.000245	0.0264	CrCbGaD
Pindolol—Atenolol—ADRB2—stomach cancer	0.000243	0.0261	CrCbGaD
Pindolol—Alprenolol—ADRB1—stomach cancer	0.000242	0.026	CrCbGaD
Pindolol—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000242	0.0023	CcSEcCtD
Pindolol—Mental disorder—Capecitabine—stomach cancer	0.000241	0.0023	CcSEcCtD
Pindolol—Feeling abnormal—Irinotecan—stomach cancer	0.000241	0.00229	CcSEcCtD
Pindolol—Pain—Fluorouracil—stomach cancer	0.000239	0.00228	CcSEcCtD
Pindolol—Gastrointestinal pain—Irinotecan—stomach cancer	0.000239	0.00228	CcSEcCtD
Pindolol—Muscle spasms—Docetaxel—stomach cancer	0.000238	0.00227	CcSEcCtD
Pindolol—Bisoprolol—ADRB2—stomach cancer	0.000237	0.0255	CrCbGaD
Pindolol—Flatulence—Capecitabine—stomach cancer	0.000236	0.00225	CcSEcCtD
Pindolol—Erectile dysfunction—Methotrexate—stomach cancer	0.000236	0.00225	CcSEcCtD
Pindolol—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000234	0.00223	CcSEcCtD
Pindolol—Abdominal pain—Irinotecan—stomach cancer	0.000231	0.0022	CcSEcCtD
Pindolol—Feeling abnormal—Fluorouracil—stomach cancer	0.000231	0.0022	CcSEcCtD
Pindolol—Muscle spasms—Capecitabine—stomach cancer	0.00023	0.00219	CcSEcCtD
Pindolol—Drowsiness—Methotrexate—stomach cancer	0.000228	0.00217	CcSEcCtD
Pindolol—Depression—Methotrexate—stomach cancer	0.000228	0.00217	CcSEcCtD
Pindolol—Metoprolol—ADRB1—stomach cancer	0.000225	0.0242	CrCbGaD
Pindolol—Tremor—Capecitabine—stomach cancer	0.000224	0.00214	CcSEcCtD
Pindolol—Acebutolol—ADRB2—stomach cancer	0.000224	0.0241	CrCbGaD
Pindolol—Oxprenolol—ADRB2—stomach cancer	0.000223	0.0239	CrCbGaD
Pindolol—Syncope—Docetaxel—stomach cancer	0.000222	0.00211	CcSEcCtD
Pindolol—Conjunctivitis—Methotrexate—stomach cancer	0.000222	0.00211	CcSEcCtD
Pindolol—Pollakiuria—Epirubicin—stomach cancer	0.000221	0.00211	CcSEcCtD
Pindolol—Sweating—Methotrexate—stomach cancer	0.000219	0.00208	CcSEcCtD
Pindolol—Palpitations—Docetaxel—stomach cancer	0.000219	0.00208	CcSEcCtD
Pindolol—Weight increased—Epirubicin—stomach cancer	0.000218	0.00208	CcSEcCtD
Pindolol—Loss of consciousness—Docetaxel—stomach cancer	0.000217	0.00207	CcSEcCtD
Pindolol—Alprenolol—HTR1A—stomach cancer	0.000217	0.0233	CrCbGaD
Pindolol—Vertigo—Capecitabine—stomach cancer	0.000215	0.00205	CcSEcCtD
Pindolol—Syncope—Capecitabine—stomach cancer	0.000215	0.00205	CcSEcCtD
Pindolol—Drowsiness—Epirubicin—stomach cancer	0.000214	0.00204	CcSEcCtD
Pindolol—Palpitations—Capecitabine—stomach cancer	0.000212	0.00202	CcSEcCtD
Pindolol—Myalgia—Docetaxel—stomach cancer	0.000211	0.00201	CcSEcCtD
Pindolol—Chest pain—Docetaxel—stomach cancer	0.000211	0.00201	CcSEcCtD
Pindolol—Arthralgia—Docetaxel—stomach cancer	0.000211	0.00201	CcSEcCtD
Pindolol—Loss of consciousness—Capecitabine—stomach cancer	0.000211	0.00201	CcSEcCtD
Pindolol—Asthenia—Irinotecan—stomach cancer	0.00021	0.002	CcSEcCtD
Pindolol—Conjunctivitis—Epirubicin—stomach cancer	0.000208	0.00198	CcSEcCtD
Pindolol—Dry mouth—Docetaxel—stomach cancer	0.000206	0.00196	CcSEcCtD
Pindolol—Sweating—Epirubicin—stomach cancer	0.000205	0.00195	CcSEcCtD
Pindolol—Pollakiuria—Doxorubicin—stomach cancer	0.000205	0.00195	CcSEcCtD
Pindolol—Arthralgia—Capecitabine—stomach cancer	0.000204	0.00194	CcSEcCtD
Pindolol—Chest pain—Capecitabine—stomach cancer	0.000204	0.00194	CcSEcCtD
Pindolol—Myalgia—Capecitabine—stomach cancer	0.000204	0.00194	CcSEcCtD
Pindolol—Confusional state—Docetaxel—stomach cancer	0.000204	0.00194	CcSEcCtD
Pindolol—Alprenolol—ADRB2—stomach cancer	0.000204	0.0219	CrCbGaD
Pindolol—Anxiety—Capecitabine—stomach cancer	0.000203	0.00194	CcSEcCtD
Pindolol—Oedema—Docetaxel—stomach cancer	0.000202	0.00192	CcSEcCtD
Pindolol—Weight increased—Doxorubicin—stomach cancer	0.000202	0.00192	CcSEcCtD
Pindolol—Diarrhoea—Irinotecan—stomach cancer	0.0002	0.0019	CcSEcCtD
Pindolol—Dry mouth—Capecitabine—stomach cancer	0.000199	0.0019	CcSEcCtD
Pindolol—Shock—Docetaxel—stomach cancer	0.000199	0.00189	CcSEcCtD
Pindolol—Nervous system disorder—Docetaxel—stomach cancer	0.000198	0.00189	CcSEcCtD
Pindolol—Pruritus—Fluorouracil—stomach cancer	0.000198	0.00189	CcSEcCtD
Pindolol—Drowsiness—Doxorubicin—stomach cancer	0.000198	0.00188	CcSEcCtD
Pindolol—Visual impairment—Methotrexate—stomach cancer	0.000197	0.00188	CcSEcCtD
Pindolol—Confusional state—Capecitabine—stomach cancer	0.000197	0.00188	CcSEcCtD
Pindolol—Tachycardia—Docetaxel—stomach cancer	0.000197	0.00188	CcSEcCtD
Pindolol—Oedema—Capecitabine—stomach cancer	0.000196	0.00186	CcSEcCtD
Pindolol—Bradycardia—Epirubicin—stomach cancer	0.000195	0.00186	CcSEcCtD
Pindolol—Dizziness—Irinotecan—stomach cancer	0.000193	0.00184	CcSEcCtD
Pindolol—Shock—Capecitabine—stomach cancer	0.000192	0.00183	CcSEcCtD
Pindolol—Conjunctivitis—Doxorubicin—stomach cancer	0.000192	0.00183	CcSEcCtD
Pindolol—Nervous system disorder—Capecitabine—stomach cancer	0.000192	0.00183	CcSEcCtD
Pindolol—Diarrhoea—Fluorouracil—stomach cancer	0.000191	0.00182	CcSEcCtD
Pindolol—Tinnitus—Methotrexate—stomach cancer	0.000191	0.00182	CcSEcCtD
Pindolol—Tachycardia—Capecitabine—stomach cancer	0.000191	0.00182	CcSEcCtD
Pindolol—Cardiac disorder—Methotrexate—stomach cancer	0.00019	0.00181	CcSEcCtD
Pindolol—Sweating—Doxorubicin—stomach cancer	0.000189	0.00181	CcSEcCtD
Pindolol—Metoprolol—ADRB2—stomach cancer	0.000189	0.0204	CrCbGaD
Pindolol—Hyperhidrosis—Capecitabine—stomach cancer	0.000189	0.0018	CcSEcCtD
Pindolol—Hypotension—Docetaxel—stomach cancer	0.000189	0.0018	CcSEcCtD
Pindolol—Angiopathy—Methotrexate—stomach cancer	0.000186	0.00177	CcSEcCtD
Pindolol—Vomiting—Irinotecan—stomach cancer	0.000186	0.00177	CcSEcCtD
Pindolol—Dizziness—Fluorouracil—stomach cancer	0.000185	0.00176	CcSEcCtD
Pindolol—Visual impairment—Epirubicin—stomach cancer	0.000185	0.00176	CcSEcCtD
Pindolol—Mediastinal disorder—Methotrexate—stomach cancer	0.000185	0.00176	CcSEcCtD
Pindolol—Rash—Irinotecan—stomach cancer	0.000184	0.00176	CcSEcCtD
Pindolol—Dermatitis—Irinotecan—stomach cancer	0.000184	0.00175	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000184	0.00175	CcSEcCtD
Pindolol—Headache—Irinotecan—stomach cancer	0.000183	0.00174	CcSEcCtD
Pindolol—Hypotension—Capecitabine—stomach cancer	0.000183	0.00174	CcSEcCtD
Pindolol—Insomnia—Docetaxel—stomach cancer	0.000183	0.00174	CcSEcCtD
Pindolol—Paraesthesia—Docetaxel—stomach cancer	0.000181	0.00173	CcSEcCtD
Pindolol—Bradycardia—Doxorubicin—stomach cancer	0.000181	0.00172	CcSEcCtD
Pindolol—Dyspnoea—Docetaxel—stomach cancer	0.00018	0.00172	CcSEcCtD
Pindolol—Somnolence—Docetaxel—stomach cancer	0.00018	0.00171	CcSEcCtD
Pindolol—Mental disorder—Methotrexate—stomach cancer	0.000179	0.00171	CcSEcCtD
Pindolol—Tinnitus—Epirubicin—stomach cancer	0.000179	0.0017	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000178	0.0017	CcSEcCtD
Pindolol—Cardiac disorder—Epirubicin—stomach cancer	0.000178	0.0017	CcSEcCtD
Pindolol—Vomiting—Fluorouracil—stomach cancer	0.000178	0.0017	CcSEcCtD
Pindolol—Dyspepsia—Docetaxel—stomach cancer	0.000178	0.00169	CcSEcCtD
Pindolol—Insomnia—Capecitabine—stomach cancer	0.000177	0.00169	CcSEcCtD
Pindolol—Rash—Fluorouracil—stomach cancer	0.000176	0.00168	CcSEcCtD
Pindolol—Dermatitis—Fluorouracil—stomach cancer	0.000176	0.00168	CcSEcCtD
Pindolol—Paraesthesia—Capecitabine—stomach cancer	0.000176	0.00167	CcSEcCtD
Pindolol—Headache—Fluorouracil—stomach cancer	0.000175	0.00167	CcSEcCtD
Pindolol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000174	0.00166	CcSEcCtD
Pindolol—Dyspnoea—Capecitabine—stomach cancer	0.000174	0.00166	CcSEcCtD
Pindolol—Fatigue—Docetaxel—stomach cancer	0.000174	0.00166	CcSEcCtD
Pindolol—Angiopathy—Epirubicin—stomach cancer	0.000174	0.00166	CcSEcCtD
Pindolol—Nausea—Irinotecan—stomach cancer	0.000174	0.00165	CcSEcCtD
Pindolol—Mediastinal disorder—Epirubicin—stomach cancer	0.000173	0.00165	CcSEcCtD
Pindolol—Pain—Docetaxel—stomach cancer	0.000173	0.00165	CcSEcCtD
Pindolol—Constipation—Docetaxel—stomach cancer	0.000173	0.00165	CcSEcCtD
Pindolol—Dyspepsia—Capecitabine—stomach cancer	0.000172	0.00164	CcSEcCtD
Pindolol—Visual impairment—Doxorubicin—stomach cancer	0.000171	0.00163	CcSEcCtD
Pindolol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000169	0.00161	CcSEcCtD
Pindolol—Fatigue—Capecitabine—stomach cancer	0.000169	0.00161	CcSEcCtD
Pindolol—Mental disorder—Epirubicin—stomach cancer	0.000168	0.0016	CcSEcCtD
Pindolol—Pain—Capecitabine—stomach cancer	0.000167	0.00159	CcSEcCtD
Pindolol—Constipation—Capecitabine—stomach cancer	0.000167	0.00159	CcSEcCtD
Pindolol—Feeling abnormal—Docetaxel—stomach cancer	0.000166	0.00159	CcSEcCtD
Pindolol—Nausea—Fluorouracil—stomach cancer	0.000166	0.00158	CcSEcCtD
Pindolol—Tinnitus—Doxorubicin—stomach cancer	0.000165	0.00158	CcSEcCtD
Pindolol—Gastrointestinal pain—Docetaxel—stomach cancer	0.000165	0.00157	CcSEcCtD
Pindolol—Cardiac disorder—Doxorubicin—stomach cancer	0.000165	0.00157	CcSEcCtD
Pindolol—Flatulence—Epirubicin—stomach cancer	0.000164	0.00157	CcSEcCtD
Pindolol—Tension—Epirubicin—stomach cancer	0.000164	0.00156	CcSEcCtD
Pindolol—Nervousness—Epirubicin—stomach cancer	0.000162	0.00154	CcSEcCtD
Pindolol—Feeling abnormal—Capecitabine—stomach cancer	0.000161	0.00154	CcSEcCtD
Pindolol—Angiopathy—Doxorubicin—stomach cancer	0.000161	0.00153	CcSEcCtD
Pindolol—Muscle spasms—Epirubicin—stomach cancer	0.00016	0.00153	CcSEcCtD
Pindolol—Vertigo—Methotrexate—stomach cancer	0.00016	0.00153	CcSEcCtD
Pindolol—Gastrointestinal pain—Capecitabine—stomach cancer	0.00016	0.00152	CcSEcCtD
Pindolol—Mediastinal disorder—Doxorubicin—stomach cancer	0.00016	0.00152	CcSEcCtD
Pindolol—Isoprenaline—ADRB1—stomach cancer	0.00016	0.0172	CrCbGaD
Pindolol—Abdominal pain—Docetaxel—stomach cancer	0.00016	0.00152	CcSEcCtD
Pindolol—Mental disorder—Doxorubicin—stomach cancer	0.000155	0.00148	CcSEcCtD
Pindolol—Abdominal pain—Capecitabine—stomach cancer	0.000155	0.00147	CcSEcCtD
Pindolol—Flatulence—Doxorubicin—stomach cancer	0.000152	0.00145	CcSEcCtD
Pindolol—Chest pain—Methotrexate—stomach cancer	0.000152	0.00145	CcSEcCtD
Pindolol—Myalgia—Methotrexate—stomach cancer	0.000152	0.00145	CcSEcCtD
Pindolol—Arthralgia—Methotrexate—stomach cancer	0.000152	0.00145	CcSEcCtD
Pindolol—Tension—Doxorubicin—stomach cancer	0.000152	0.00144	CcSEcCtD
Pindolol—Nervousness—Doxorubicin—stomach cancer	0.00015	0.00143	CcSEcCtD
Pindolol—Vertigo—Epirubicin—stomach cancer	0.00015	0.00143	CcSEcCtD
Pindolol—Syncope—Epirubicin—stomach cancer	0.00015	0.00143	CcSEcCtD
Pindolol—Muscle spasms—Doxorubicin—stomach cancer	0.000148	0.00141	CcSEcCtD
Pindolol—Palpitations—Epirubicin—stomach cancer	0.000148	0.00141	CcSEcCtD
Pindolol—Confusional state—Methotrexate—stomach cancer	0.000147	0.0014	CcSEcCtD
Pindolol—Loss of consciousness—Epirubicin—stomach cancer	0.000147	0.0014	CcSEcCtD
Pindolol—Asthenia—Docetaxel—stomach cancer	0.000145	0.00138	CcSEcCtD
Pindolol—Pruritus—Docetaxel—stomach cancer	0.000143	0.00136	CcSEcCtD
Pindolol—Nervous system disorder—Methotrexate—stomach cancer	0.000143	0.00136	CcSEcCtD
Pindolol—Myalgia—Epirubicin—stomach cancer	0.000142	0.00135	CcSEcCtD
Pindolol—Arthralgia—Epirubicin—stomach cancer	0.000142	0.00135	CcSEcCtD
Pindolol—Chest pain—Epirubicin—stomach cancer	0.000142	0.00135	CcSEcCtD
Pindolol—Anxiety—Epirubicin—stomach cancer	0.000142	0.00135	CcSEcCtD
Pindolol—Hyperhidrosis—Methotrexate—stomach cancer	0.000141	0.00134	CcSEcCtD
Pindolol—Asthenia—Capecitabine—stomach cancer	0.00014	0.00134	CcSEcCtD
Pindolol—Dry mouth—Epirubicin—stomach cancer	0.000139	0.00132	CcSEcCtD
Pindolol—Vertigo—Doxorubicin—stomach cancer	0.000139	0.00132	CcSEcCtD
Pindolol—Syncope—Doxorubicin—stomach cancer	0.000138	0.00132	CcSEcCtD
Pindolol—Pruritus—Capecitabine—stomach cancer	0.000138	0.00132	CcSEcCtD
Pindolol—Diarrhoea—Docetaxel—stomach cancer	0.000138	0.00132	CcSEcCtD
Pindolol—Confusional state—Epirubicin—stomach cancer	0.000137	0.00131	CcSEcCtD
Pindolol—Palpitations—Doxorubicin—stomach cancer	0.000136	0.0013	CcSEcCtD
Pindolol—Oedema—Epirubicin—stomach cancer	0.000136	0.0013	CcSEcCtD
Pindolol—Hypotension—Methotrexate—stomach cancer	0.000136	0.0013	CcSEcCtD
Pindolol—Loss of consciousness—Doxorubicin—stomach cancer	0.000136	0.00129	CcSEcCtD
Pindolol—Isoprenaline—ADRB2—stomach cancer	0.000134	0.0144	CrCbGaD
Pindolol—Shock—Epirubicin—stomach cancer	0.000134	0.00128	CcSEcCtD
Pindolol—Diarrhoea—Capecitabine—stomach cancer	0.000134	0.00127	CcSEcCtD
Pindolol—Nervous system disorder—Epirubicin—stomach cancer	0.000134	0.00127	CcSEcCtD
Pindolol—Dizziness—Docetaxel—stomach cancer	0.000134	0.00127	CcSEcCtD
Pindolol—Tachycardia—Epirubicin—stomach cancer	0.000133	0.00127	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000133	0.00126	CcSEcCtD
Pindolol—Hyperhidrosis—Epirubicin—stomach cancer	0.000132	0.00125	CcSEcCtD
Pindolol—Insomnia—Methotrexate—stomach cancer	0.000132	0.00125	CcSEcCtD
Pindolol—Arthralgia—Doxorubicin—stomach cancer	0.000131	0.00125	CcSEcCtD
Pindolol—Chest pain—Doxorubicin—stomach cancer	0.000131	0.00125	CcSEcCtD
Pindolol—Myalgia—Doxorubicin—stomach cancer	0.000131	0.00125	CcSEcCtD
Pindolol—Anxiety—Doxorubicin—stomach cancer	0.000131	0.00125	CcSEcCtD
Pindolol—Paraesthesia—Methotrexate—stomach cancer	0.000131	0.00125	CcSEcCtD
Pindolol—Dyspnoea—Methotrexate—stomach cancer	0.00013	0.00124	CcSEcCtD
Pindolol—Somnolence—Methotrexate—stomach cancer	0.000129	0.00123	CcSEcCtD
Pindolol—Dizziness—Capecitabine—stomach cancer	0.000129	0.00123	CcSEcCtD
Pindolol—Dry mouth—Doxorubicin—stomach cancer	0.000129	0.00123	CcSEcCtD
Pindolol—Vomiting—Docetaxel—stomach cancer	0.000128	0.00122	CcSEcCtD
Pindolol—Dyspepsia—Methotrexate—stomach cancer	0.000128	0.00122	CcSEcCtD
Pindolol—Rash—Docetaxel—stomach cancer	0.000127	0.00121	CcSEcCtD
Pindolol—Hypotension—Epirubicin—stomach cancer	0.000127	0.00121	CcSEcCtD
Pindolol—Dermatitis—Docetaxel—stomach cancer	0.000127	0.00121	CcSEcCtD
Pindolol—Confusional state—Doxorubicin—stomach cancer	0.000127	0.00121	CcSEcCtD
Pindolol—Headache—Docetaxel—stomach cancer	0.000127	0.00121	CcSEcCtD
Pindolol—Oedema—Doxorubicin—stomach cancer	0.000126	0.0012	CcSEcCtD
Pindolol—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000126	0.0012	CcSEcCtD
Pindolol—Fatigue—Methotrexate—stomach cancer	0.000125	0.0012	CcSEcCtD
Pindolol—Pain—Methotrexate—stomach cancer	0.000124	0.00119	CcSEcCtD
Pindolol—Vomiting—Capecitabine—stomach cancer	0.000124	0.00118	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000124	0.00118	CcSEcCtD
Pindolol—Shock—Doxorubicin—stomach cancer	0.000124	0.00118	CcSEcCtD
Pindolol—Nervous system disorder—Doxorubicin—stomach cancer	0.000124	0.00118	CcSEcCtD
Pindolol—Rash—Capecitabine—stomach cancer	0.000123	0.00117	CcSEcCtD
Pindolol—Insomnia—Epirubicin—stomach cancer	0.000123	0.00117	CcSEcCtD
Pindolol—Dermatitis—Capecitabine—stomach cancer	0.000123	0.00117	CcSEcCtD
Pindolol—Tachycardia—Doxorubicin—stomach cancer	0.000123	0.00117	CcSEcCtD
Pindolol—Headache—Capecitabine—stomach cancer	0.000122	0.00117	CcSEcCtD
Pindolol—Paraesthesia—Epirubicin—stomach cancer	0.000122	0.00117	CcSEcCtD
Pindolol—Hyperhidrosis—Doxorubicin—stomach cancer	0.000122	0.00116	CcSEcCtD
Pindolol—Dyspnoea—Epirubicin—stomach cancer	0.000121	0.00116	CcSEcCtD
Pindolol—Somnolence—Epirubicin—stomach cancer	0.000121	0.00115	CcSEcCtD
Pindolol—Nausea—Docetaxel—stomach cancer	0.00012	0.00114	CcSEcCtD
Pindolol—Feeling abnormal—Methotrexate—stomach cancer	0.00012	0.00114	CcSEcCtD
Pindolol—Dyspepsia—Epirubicin—stomach cancer	0.00012	0.00114	CcSEcCtD
Pindolol—Gastrointestinal pain—Methotrexate—stomach cancer	0.000119	0.00113	CcSEcCtD
Pindolol—Hypotension—Doxorubicin—stomach cancer	0.000118	0.00112	CcSEcCtD
Pindolol—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000118	0.00112	CcSEcCtD
Pindolol—Fatigue—Epirubicin—stomach cancer	0.000117	0.00112	CcSEcCtD
Pindolol—Pain—Epirubicin—stomach cancer	0.000116	0.00111	CcSEcCtD
Pindolol—Constipation—Epirubicin—stomach cancer	0.000116	0.00111	CcSEcCtD
Pindolol—Nausea—Capecitabine—stomach cancer	0.000116	0.00111	CcSEcCtD
Pindolol—Abdominal pain—Methotrexate—stomach cancer	0.000115	0.0011	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000115	0.00109	CcSEcCtD
Pindolol—Insomnia—Doxorubicin—stomach cancer	0.000114	0.00109	CcSEcCtD
Pindolol—Propranolol—ADRB1—stomach cancer	0.000114	0.0122	CrCbGaD
Pindolol—Paraesthesia—Doxorubicin—stomach cancer	0.000113	0.00108	CcSEcCtD
Pindolol—Dyspnoea—Doxorubicin—stomach cancer	0.000112	0.00107	CcSEcCtD
Pindolol—Feeling abnormal—Epirubicin—stomach cancer	0.000112	0.00107	CcSEcCtD
Pindolol—Somnolence—Doxorubicin—stomach cancer	0.000112	0.00107	CcSEcCtD
Pindolol—Gastrointestinal pain—Epirubicin—stomach cancer	0.000111	0.00106	CcSEcCtD
Pindolol—Dyspepsia—Doxorubicin—stomach cancer	0.000111	0.00106	CcSEcCtD
Pindolol—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000109	0.00104	CcSEcCtD
Pindolol—Fatigue—Doxorubicin—stomach cancer	0.000109	0.00104	CcSEcCtD
Pindolol—Pain—Doxorubicin—stomach cancer	0.000108	0.00103	CcSEcCtD
Pindolol—Constipation—Doxorubicin—stomach cancer	0.000108	0.00103	CcSEcCtD
Pindolol—Abdominal pain—Epirubicin—stomach cancer	0.000108	0.00103	CcSEcCtD
Pindolol—Asthenia—Methotrexate—stomach cancer	0.000104	0.000995	CcSEcCtD
Pindolol—Feeling abnormal—Doxorubicin—stomach cancer	0.000104	0.00099	CcSEcCtD
Pindolol—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000103	0.000982	CcSEcCtD
Pindolol—Pruritus—Methotrexate—stomach cancer	0.000103	0.000981	CcSEcCtD
Pindolol—Propranolol—HTR1A—stomach cancer	0.000102	0.0109	CrCbGaD
Pindolol—Abdominal pain—Doxorubicin—stomach cancer	9.96e-05	0.000949	CcSEcCtD
Pindolol—Diarrhoea—Methotrexate—stomach cancer	9.96e-05	0.000949	CcSEcCtD
Pindolol—Asthenia—Epirubicin—stomach cancer	9.77e-05	0.000931	CcSEcCtD
Pindolol—Pruritus—Epirubicin—stomach cancer	9.64e-05	0.000918	CcSEcCtD
Pindolol—Dizziness—Methotrexate—stomach cancer	9.63e-05	0.000917	CcSEcCtD
Pindolol—Propranolol—ADRB2—stomach cancer	9.55e-05	0.0103	CrCbGaD
Pindolol—Diarrhoea—Epirubicin—stomach cancer	9.32e-05	0.000888	CcSEcCtD
Pindolol—Vomiting—Methotrexate—stomach cancer	9.26e-05	0.000882	CcSEcCtD
Pindolol—Rash—Methotrexate—stomach cancer	9.18e-05	0.000874	CcSEcCtD
Pindolol—Dermatitis—Methotrexate—stomach cancer	9.17e-05	0.000874	CcSEcCtD
Pindolol—Headache—Methotrexate—stomach cancer	9.12e-05	0.000869	CcSEcCtD
Pindolol—Asthenia—Doxorubicin—stomach cancer	9.04e-05	0.000862	CcSEcCtD
Pindolol—Dizziness—Epirubicin—stomach cancer	9.01e-05	0.000858	CcSEcCtD
Pindolol—Pruritus—Doxorubicin—stomach cancer	8.92e-05	0.00085	CcSEcCtD
Pindolol—Vomiting—Epirubicin—stomach cancer	8.66e-05	0.000825	CcSEcCtD
Pindolol—Nausea—Methotrexate—stomach cancer	8.65e-05	0.000824	CcSEcCtD
Pindolol—Diarrhoea—Doxorubicin—stomach cancer	8.62e-05	0.000822	CcSEcCtD
Pindolol—Rash—Epirubicin—stomach cancer	8.59e-05	0.000818	CcSEcCtD
Pindolol—Dermatitis—Epirubicin—stomach cancer	8.58e-05	0.000818	CcSEcCtD
Pindolol—Headache—Epirubicin—stomach cancer	8.53e-05	0.000813	CcSEcCtD
Pindolol—Dizziness—Doxorubicin—stomach cancer	8.33e-05	0.000794	CcSEcCtD
Pindolol—Nausea—Epirubicin—stomach cancer	8.09e-05	0.000771	CcSEcCtD
Pindolol—Vomiting—Doxorubicin—stomach cancer	8.01e-05	0.000764	CcSEcCtD
Pindolol—Rash—Doxorubicin—stomach cancer	7.95e-05	0.000757	CcSEcCtD
Pindolol—Dermatitis—Doxorubicin—stomach cancer	7.94e-05	0.000757	CcSEcCtD
Pindolol—Headache—Doxorubicin—stomach cancer	7.9e-05	0.000752	CcSEcCtD
Pindolol—Nausea—Doxorubicin—stomach cancer	7.49e-05	0.000713	CcSEcCtD
Pindolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	1.44e-05	0.000278	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PRKCB—stomach cancer	1.44e-05	0.000277	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	1.43e-05	0.000277	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6ST—stomach cancer	1.43e-05	0.000276	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SMAD4—stomach cancer	1.42e-05	0.000275	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	1.41e-05	0.000273	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—CXCL8—stomach cancer	1.41e-05	0.000272	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	1.41e-05	0.000272	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RPS6—stomach cancer	1.4e-05	0.000271	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PRKCB—stomach cancer	1.38e-05	0.000267	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6ST—stomach cancer	1.38e-05	0.000266	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—APC—stomach cancer	1.37e-05	0.000266	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SREBF2—stomach cancer	1.35e-05	0.000261	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—FYN—stomach cancer	1.35e-05	0.000261	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	1.35e-05	0.00026	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—RORA—stomach cancer	1.33e-05	0.000258	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	1.32e-05	0.000255	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—MAPK3—stomach cancer	1.32e-05	0.000254	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HBEGF—stomach cancer	1.29e-05	0.000249	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	1.28e-05	0.000248	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CXCL8—stomach cancer	1.28e-05	0.000247	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6R—stomach cancer	1.28e-05	0.000247	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	1.28e-05	0.000246	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—FGFR2—stomach cancer	1.27e-05	0.000245	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	1.25e-05	0.000242	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—MAPK1—stomach cancer	1.25e-05	0.000242	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—EGFR—stomach cancer	1.25e-05	0.000242	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALDOB—stomach cancer	1.25e-05	0.000241	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	1.25e-05	0.000241	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	1.24e-05	0.00024	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6R—stomach cancer	1.23e-05	0.000237	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—RHOA—stomach cancer	1.22e-05	0.000236	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	1.22e-05	0.000235	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—PIK3CA—stomach cancer	1.2e-05	0.000231	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SERPINE1—stomach cancer	1.2e-05	0.000231	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	1.19e-05	0.00023	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADRB2—stomach cancer	1.19e-05	0.00023	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—KRAS—stomach cancer	1.18e-05	0.000229	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PPP2R1A—stomach cancer	1.17e-05	0.000225	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALOX5—stomach cancer	1.16e-05	0.000224	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IRS2—stomach cancer	1.16e-05	0.000224	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	1.16e-05	0.000224	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—RHOA—stomach cancer	1.15e-05	0.000223	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—DPYD—stomach cancer	1.14e-05	0.000221	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NOS3—stomach cancer	1.14e-05	0.00022	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	1.13e-05	0.000219	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	1.13e-05	0.000219	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CAV1—stomach cancer	1.12e-05	0.000217	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—APOA1—stomach cancer	1.12e-05	0.000217	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	1.12e-05	0.000216	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—RHOA—stomach cancer	1.11e-05	0.000214	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	1.11e-05	0.000214	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	1.1e-05	0.000212	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—PIK3CA—stomach cancer	1.09e-05	0.00021	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SMAD4—stomach cancer	1.08e-05	0.000209	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FYN—stomach cancer	1.07e-05	0.000208	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—CXCL8—stomach cancer	1.07e-05	0.000207	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PRKCB—stomach cancer	1.07e-05	0.000207	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ERBB2—stomach cancer	1.07e-05	0.000206	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6ST—stomach cancer	1.07e-05	0.000206	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FYN—stomach cancer	1.05e-05	0.000203	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FYN—stomach cancer	1.03e-05	0.000199	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—APC—stomach cancer	1.02e-05	0.000198	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	1.02e-05	0.000196	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CXCL8—stomach cancer	1.01e-05	0.000196	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTT1—stomach cancer	1.01e-05	0.000195	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	1.01e-05	0.000195	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—HRAS—stomach cancer	1.01e-05	0.000194	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP2A6—stomach cancer	9.99e-06	0.000193	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	9.95e-06	0.000192	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CDKN1B—stomach cancer	9.89e-06	0.000191	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	9.87e-06	0.000191	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—MAPK3—stomach cancer	9.81e-06	0.00019	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CXCL8—stomach cancer	9.73e-06	0.000188	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKR1C3—stomach cancer	9.72e-06	0.000188	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FGFR2—stomach cancer	9.65e-06	0.000186	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—IL6—stomach cancer	9.63e-06	0.000186	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6R—stomach cancer	9.51e-06	0.000184	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ENO1—stomach cancer	9.47e-06	0.000183	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CCND1—stomach cancer	9.43e-06	0.000182	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—JUN—stomach cancer	9.41e-06	0.000182	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—MAPK1—stomach cancer	9.34e-06	0.00018	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—EGFR—stomach cancer	9.33e-06	0.00018	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	9.24e-06	0.000178	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MMP9—stomach cancer	9.16e-06	0.000177	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CDKN1A—stomach cancer	9.12e-06	0.000176	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	9.04e-06	0.000175	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	8.96e-06	0.000173	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	8.94e-06	0.000173	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—PIK3CA—stomach cancer	8.92e-06	0.000172	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SERPINE1—stomach cancer	8.91e-06	0.000172	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MAPK8—stomach cancer	8.9e-06	0.000172	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IRS2—stomach cancer	8.84e-06	0.000171	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—KRAS—stomach cancer	8.82e-06	0.00017	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	8.76e-06	0.000169	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	8.74e-06	0.000169	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RHOA—stomach cancer	8.59e-06	0.000166	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CAV1—stomach cancer	8.57e-06	0.000165	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APOA1—stomach cancer	8.55e-06	0.000165	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	8.53e-06	0.000165	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NOS3—stomach cancer	8.5e-06	0.000164	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	8.49e-06	0.000164	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CD44—stomach cancer	8.4e-06	0.000162	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	8.34e-06	0.000161	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	8.31e-06	0.00016	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—VEGFA—stomach cancer	8.22e-06	0.000159	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APC—stomach cancer	8.16e-06	0.000158	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PRKCB—stomach cancer	8.16e-06	0.000158	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—STAT3—stomach cancer	8.14e-06	0.000157	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6ST—stomach cancer	8.12e-06	0.000157	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—PIK3CA—stomach cancer	8.1e-06	0.000156	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APC—stomach cancer	7.98e-06	0.000154	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ERBB2—stomach cancer	7.96e-06	0.000154	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	7.81e-06	0.000151	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APC—stomach cancer	7.8e-06	0.000151	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MAPK3—stomach cancer	7.78e-06	0.00015	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	7.64e-06	0.000148	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	7.58e-06	0.000146	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MYC—stomach cancer	7.56e-06	0.000146	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CXCL8—stomach cancer	7.54e-06	0.000146	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—HRAS—stomach cancer	7.5e-06	0.000145	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—MAPK3—stomach cancer	7.47e-06	0.000144	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	7.44e-06	0.000144	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	7.43e-06	0.000144	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	7.41e-06	0.000143	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MAPK1—stomach cancer	7.4e-06	0.000143	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EGFR—stomach cancer	7.4e-06	0.000143	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDKN1B—stomach cancer	7.37e-06	0.000142	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	7.27e-06	0.00014	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	7.27e-06	0.00014	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6R—stomach cancer	7.25e-06	0.00014	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—IL6—stomach cancer	7.17e-06	0.000139	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPP2R1A—stomach cancer	7.14e-06	0.000138	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—MAPK1—stomach cancer	7.11e-06	0.000137	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—EGFR—stomach cancer	7.11e-06	0.000137	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	7.1e-06	0.000137	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	7.09e-06	0.000137	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCND1—stomach cancer	7.03e-06	0.000136	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	7.02e-06	0.000136	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—JUN—stomach cancer	7.01e-06	0.000135	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTP1—stomach cancer	7.01e-06	0.000135	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—KRAS—stomach cancer	6.99e-06	0.000135	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	6.95e-06	0.000134	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	6.94e-06	0.000134	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HMOX1—stomach cancer	6.91e-06	0.000133	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	6.87e-06	0.000133	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	6.84e-06	0.000132	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MMP9—stomach cancer	6.82e-06	0.000132	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDKN1A—stomach cancer	6.8e-06	0.000131	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3CA—stomach cancer	6.8e-06	0.000131	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SERPINE1—stomach cancer	6.79e-06	0.000131	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	6.77e-06	0.000131	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—KRAS—stomach cancer	6.72e-06	0.00013	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	6.69e-06	0.000129	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAPK8—stomach cancer	6.64e-06	0.000128	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	6.63e-06	0.000128	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RHOA—stomach cancer	6.55e-06	0.000126	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TYMS—stomach cancer	6.51e-06	0.000126	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOS3—stomach cancer	6.48e-06	0.000125	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	6.45e-06	0.000125	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTM1—stomach cancer	6.44e-06	0.000124	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3CA—stomach cancer	6.42e-06	0.000124	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	6.34e-06	0.000122	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	6.31e-06	0.000122	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TP53—stomach cancer	6.21e-06	0.00012	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	6.2e-06	0.00012	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	6.17e-06	0.000119	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—VEGFA—stomach cancer	6.13e-06	0.000118	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—STAT3—stomach cancer	6.07e-06	0.000117	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ERBB2—stomach cancer	6.06e-06	0.000117	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ERCC2—stomach cancer	6.05e-06	0.000117	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	6.01e-06	0.000116	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	5.97e-06	0.000115	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HRAS—stomach cancer	5.94e-06	0.000115	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	5.88e-06	0.000114	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	5.87e-06	0.000113	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	5.84e-06	0.000113	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAPK3—stomach cancer	5.8e-06	0.000112	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCL8—stomach cancer	5.75e-06	0.000111	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	5.74e-06	0.000111	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	5.71e-06	0.00011	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HRAS—stomach cancer	5.71e-06	0.00011	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—MTHFR—stomach cancer	5.69e-06	0.00011	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6—stomach cancer	5.69e-06	0.00011	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MYC—stomach cancer	5.64e-06	0.000109	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	5.61e-06	0.000108	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	5.6e-06	0.000108	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	5.59e-06	0.000108	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—JUN—stomach cancer	5.59e-06	0.000108	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAPK1—stomach cancer	5.52e-06	0.000107	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EGFR—stomach cancer	5.51e-06	0.000107	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	5.48e-06	0.000106	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6—stomach cancer	5.46e-06	0.000106	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—JUN—stomach cancer	5.46e-06	0.000106	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	5.43e-06	0.000105	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	5.41e-06	0.000105	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCND1—stomach cancer	5.35e-06	0.000103	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—JUN—stomach cancer	5.34e-06	0.000103	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	5.32e-06	0.000103	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	5.3e-06	0.000102	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	5.29e-06	0.000102	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CAV1—stomach cancer	5.25e-06	0.000101	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOA1—stomach cancer	5.24e-06	0.000101	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—KRAS—stomach cancer	5.21e-06	0.000101	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MMP9—stomach cancer	5.2e-06	0.0001	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	5.18e-06	0.0001	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	5.17e-06	9.99e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAPK8—stomach cancer	5.06e-06	9.76e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	4.88e-06	9.43e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	4.83e-06	9.33e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	4.79e-06	9.24e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	4.77e-06	9.22e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	4.73e-06	9.13e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—VEGFA—stomach cancer	4.67e-06	9.02e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TP53—stomach cancer	4.63e-06	8.94e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—STAT3—stomach cancer	4.62e-06	8.93e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	4.62e-06	8.92e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPARG—stomach cancer	4.61e-06	8.91e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	4.52e-06	8.72e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MYC—stomach cancer	4.49e-06	8.67e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HRAS—stomach cancer	4.43e-06	8.55e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAPK3—stomach cancer	4.42e-06	8.53e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	4.39e-06	8.48e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MYC—stomach cancer	4.39e-06	8.48e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	4.39e-06	8.48e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	4.3e-06	8.3e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	4.3e-06	8.3e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MYC—stomach cancer	4.29e-06	8.29e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6—stomach cancer	4.24e-06	8.18e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAPK1—stomach cancer	4.2e-06	8.11e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGFR—stomach cancer	4.2e-06	8.11e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	4.15e-06	8.01e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALB—stomach cancer	4.15e-06	8.01e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	4.06e-06	7.84e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NOS3—stomach cancer	3.97e-06	7.66e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KRAS—stomach cancer	3.97e-06	7.66e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	3.81e-06	7.36e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	3.73e-06	7.2e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TP53—stomach cancer	3.69e-06	7.12e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	3.65e-06	7.04e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTGS2—stomach cancer	3.63e-06	7.01e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TP53—stomach cancer	3.61e-06	6.97e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TP53—stomach cancer	3.53e-06	6.81e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	3.53e-06	6.81e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	3.45e-06	6.66e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6—stomach cancer	3.37e-06	6.52e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HRAS—stomach cancer	3.37e-06	6.51e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6—stomach cancer	3.3e-06	6.38e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6—stomach cancer	3.23e-06	6.24e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.23e-06	4.31e-05	CbGpPWpGaD
